«Kartagener

Below is an extended Kartagener patents listing. Click here to return to the Kartagener main in depth entry.

Patents :
US Patent No.	Title
5876700	Methods of hydrating lung mucous secretions with benzamil or phenamil
6451288	Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof
6551989	Preventing airway mucus production by administration of EGF-R antagonists
6566324	Preventing airway mucus production by administration of EGF-R antagonists
6612306	Respiratory nitric oxide meter
6673779	Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues
6683063	Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
6686188	Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
6689810	Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
6693077	Keratinocyte growth factor-2
6723056	Device for the collection, storage and/or transport of gas samples
6420347	Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
6417172	Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
6308703	Ventilator device
5922610	System to be used for the determination of no levels in exhaled air and diagnostic methods for disorders related to abnormal no levels
5935555	Dinucleotides useful for hydrating lung mucous secretions
6010459	Method and apparatus for the measurement of components of exhaled breath in humans
6019100	Ventilator device
6022527	Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof
6143279	Uridine 5'-diphosphate and analogs useful for treating lung diseases
6149606	Method and device for use in the diagnosis of inflammatory states in the urogenital tract
6217886	Materials and methods for making improved micelle compositions
6235266	Dinucleotides useful for the treatment of lung disease
6270747	In vitro and in vivo assay for agents which treat mucus hypersecretion
6753164	Nucleic acids encoding human serpin polypeptide HMCIS41
6770466	Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
7196164	Secreted protein HHTLF25
7232667	Keratinocyte growth factor-2 polynucleotides
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7326683	Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
7354894	Preventing airway mucus production by administration of EGF-R antagonists
7358222	Preventing airway mucus production by administration of EGF-R antagonists
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7381800	Antibodies to HBIMF63 polypeptide
7189690	Albumin fusion proteins
7163797	50 human secreted proteins
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
6846799	Preventing airway mucus production by administration of EGF-R antagonists
6878806	Human secreted protein HTEEB42
6905688	Albumin fusion proteins
6919433	Antibodies to protein HPMBQ91
6926898	Albumin fusion proteins
6946134	Albumin fusion proteins
6951924	Antibodies against secreted protein HTEBYII
6994857	Albumin fusion proteins
7026447	53 human secreted proteins
7091315	Protein HDPBQ71
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.